Suspended

IPVEvaluation of the Effects of Intrapulmonary Percussive Ventilation Using Functional Respiratory Imaging

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

intrapulmonary percussive ventilation

+ standard treatment

DeviceOther
Who is being recruted

Chronic Disease+5

+ Lung Diseases

+ Lung Diseases, Obstructive

Over 30 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: September 2011
See protocol details

Summary

Principal SponsorUniversity Hospital, Antwerp
Study ContactKris Ides, MscMore contacts
Last updated: May 28, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2011

Actual date on which the first participant was enrolled.

A Multicenter study conducted in university Hospital Antwerp (UZA) and ZNA Middelheim. Tests are taken before and after one week IPV treatment. IPV is applied for 1 week during the physical therapy treatment of chronic obstructive pulmonary desease (COPD) patients admitted to the hospital for an excarebation. The IPV treatment is an additional treatment upon the standard treatment of the patients. The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises. Patients are randomized into either the experimental group or the control group. The control group receives a standard physical therapy treatment without additional IPV treatment.

NCT01671540
Principal SponsorUniversity Hospital, Antwerp
Study ContactKris Ides, MscMore contacts
Last updated: May 28, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 30 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Chronic DiseaseLung DiseasesLung Diseases, ObstructivePathologic ProcessesRespiratory Tract DiseasesPathological Conditions, Signs and SymptomsDisease AttributesPulmonary Disease, Chronic Obstructive

Criteria

2 inclusion criteria required to participate
Mild to severe COPD
Patients admitted in the hospital for a acute exacerbation
8 exclusion criteria prevent from participating
Epilepsy
Facial deformity
Intubated
Ischemic / ventricular aritmic
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
IPV is applied for 1 week (once a day) during the physical therapy treatment of the patient

Group II

Active Comparator
The standard treatment consists out of existing drainage techniques to remove secretion out of the lungs by means of breathing control exercises

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

University Hospital Antwerp

Edegem, BelgiumOpen University Hospital Antwerp in Google Maps
SuspendedOne Study Center